Cargando…
No population left behind: Improving paediatric drug safety using informatics and systems biology
Adverse drugs effects (ADEs) in children are common and may result in disability and death. The current paediatric drug safety landscape, including clinical trials, is limited as it rarely includes children and relies on extrapolation from adults. Children are not small adults but go through an evol...
Autores principales: | Giangreco, Nicholas P., Elias, Jonathan E., Tatonetti, Nicholas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209126/ https://www.ncbi.nlm.nih.gov/pubmed/33332641 http://dx.doi.org/10.1111/bcp.14705 |
Ejemplares similares
-
TDM is dead. Long live TCI!
por: Holford, Nick, et al.
Publicado: (2020) -
Poxes great and small: The stories behind their names
por: Czinn, Amber B., et al.
Publicado: (2023) -
A Target‐Mediated Drug Disposition Model to Explain Nonlinear Pharmacokinetics of the 11β‐Hydroxysteroid Dehydrogenase Type 1 Inhibitor SPI‐62 in Healthy Adults
por: Wu, Nan, et al.
Publicado: (2021) -
Population Pharmacokinetics of Pomalidomide
por: Li, Yan, et al.
Publicado: (2015) -
Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: Disposition kinetics and pharmacology distinct from solvent-based paclitaxel
por: Chen, Nianhang, et al.
Publicado: (2014)